Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alirocumab
alnylam pharmaceuticals
amgen
biotech
boston blog main
boston top stories
clinical trials
deals
evolocumab
fda
inclisiran
life sciences
national blog main
national top stories
new york
new york blog main
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sanofi
the medicines company
What
billion
drug
fda
2
×
novartis
2
×
acquire
agreed
approved
approves
biotech
brings
called
cash
cholesterol
company
compound
copy
copycat
costly
deal
generic
injectable
journal
medco
medicine
medicines
neupogen
new
poised
quasi
ready
reports
shrinking
spending
step
street
time
today
us's
use
version
Language
unset
Current search:
novartis
×
fda
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@theverge.com
9 years ago
FDA approves the first generic copy of a costly biotech drug
